(Q36692376)

English

Improvement of the synthetic tri-peptide vaccine (S3Pvac) against porcine Taenia solium cysticercosis in search of a more effective, inexpensive and manageable vaccine

scientific article published on 23 October 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

1 reference

Europe PubMed Central

Improvement of the synthetic tri-peptide vaccine (S3Pvac) against porcine Taenia solium cysticercosis in search of a more effective, inexpensive and manageable vaccine (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

0 references

0 references

Luis Rafael Herrera Estrella

20

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

1

object named as

Edda Sciutto

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

21

object named as

Gladis Fragoso

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Aline S de Aluja

18

object named as

Aline S de Aluja

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

8

object named as

Goar Gevorkian

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Carmen Cruz-Revilla

5

object named as

Carmen Cruz-Revilla

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

15

object named as

Mirna Huerta

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

author name string

Gabriela Rosas

2

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Marisela Hernández

3

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Julio Morales

4

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Andrea Toledo

6

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Karen Manoutcharian

7

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Abel Blancas

9

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Gonzalo Acero

10

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Beatriz Hernández

11

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Jacquelynne Cervantes

12

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Raul J Bobes

13

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Fernando A Goldbaum

14

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Alicia Diaz-Orea

16

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Agnes Fleury

17

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Jose Luis Cabrera-Ponce

19

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Carlos Larralde

22

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

language of work or name

0 references

publication date

23 October 2006

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

1368-1378

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Overview of vaccines and vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

Human vaccine research and development: an overview

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

Viral hepatitis prevention by immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

Malaria vaccines: if at first you don't succeed...

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

New approaches in vaccine development for parasitic infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

Vaccination of lambs against infection with Taenia ovis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

Vaccination against ovine cysticercosis using a defined recombinant antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

Taenia saginata: vaccination against cysticercosis in cattle with recombinant oncosphere antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

Ag-ELISA and PCR for monitoring the vaccination of cattle against Taenia saginata cysticercosis using an oncospheral adhesion protein (HP6) with surface and secreted localization.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

Taenia solium: immunity in hogs to the Cysticercus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

Immunization of pigs against Taenia solium cysticercosis: factors related to effective protection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

Vaccination against Taenia solium cysticercosis in pigs using native and recombinant oncosphere antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

Synthetic peptide vaccine against Taenia solium pig cysticercosis: successful vaccination in a controlled field trial in rural Mexico

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

Induction of protection against porcine cysticercosis by vaccination with recombinant oncosphere antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

Vaccination against hydatidosis using a defined recombinant antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

Immunisation with Salmonella typhimurium-delivered glyceraldehyde-3-phosphate dehydrogenase protects mice against challenge infection with Echinococcus multilocularis eggs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

The Echinococcus multilocularis 14-3-3 protein protects mice against primary but not secondary alveolar echinococcosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

Cysticercosis vaccine: cross protecting immunity with T. solium antigens against experimental murine T. crassiceps cysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

Cysticercosis: identification and cloning of protective recombinant antigens.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

Two epitopes shared by Taenia crassiceps and Taenia solium confer protection against murine T. crassiceps cysticercosis along with a prominent T1 response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

Protective immunity against Taenia crassiceps murine cysticercosis induced by DNA vaccination with a Taenia saginata tegument antigen.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

Limitations of current diagnostic procedures for the diagnosis of Taenia solium cysticercosis in rural pigs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

Th1-type cytokines improve resistance to murine cysticercosis caused by Taenia crassiceps.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

Inhibitory role of antibodies in the development of Taenia solium and Taenia crassiceps toward reproductive and pathogenic stages

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

Th1 and Th2 indices of the immune response in pigs vaccinated against Taenia solium cysticercosis suggest various host immune strategies against the parasite

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

Altered T helper responses in CD40 and interleukin-12 deficient mice reveal a critical role for Th1 responses in eliminating the helminth parasite Taenia crassiceps

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

A STAT4-dependent Th1 response is required for resistance to the helminth parasite Taenia crassiceps.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

Intact glycans from cestode antigens are involved in innate activation of myeloid suppressor cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

Familial clustering of Taenia solium cysticercosis in the rural pigs of Mexico: hints of genetic determinants in innate and acquired resistance to infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

The role of sex steroids in the complex physiology of the host-parasite relationship: the case of the larval cestode of Taenia crassiceps

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

IN VITRO ONCOSPHERE-KILLING ASSAYS TO DETERMINE IMMUNITY TO THE LARVAE OF TAENIA PISIFORMIS, TAENIA OVIS, TAENIA SAGINATA, AND TAENIA SOLIUM

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

Immunization against porcine cysticercosis in an endemic area in Mexico: a field and laboratory study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

Field trial for reducing porcine Taenia solium cysticercosis in Mexico by systematic vaccination of pigs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

Effective immune protection of pigs against cysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

Immunization of pigs with culture antigens of Taenia solium

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

Recombinant bacteriophage-based multiepitope vaccine against Taenia solium pig cysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

Immune response and protection elicited by DNA immunisation against Taenia cysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

DNA vaccine against Taenia solium cysticercosis expressed as a modified hepatitis B virus core particle containing three epitopes shared by Taenia crassiceps and Taenia solium

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

Protection of pigs against Taenia solium cysticercosis using recombinant antigen or in combination with DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

Induction of protection against porcine cysticercosis in growing pigs by DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

Deciphering western blots of tapeworm antigens (Taenia solium, Echinococcus granulosus, and Taenia crassiceps) reacting with sera from neurocysticercosis and hydatid disease patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

Immunological responses of the mammalian host against tapeworm infections. XI. Antigen sharing among Taenia pisiformis, T. hydatigena, and T. ovis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

Demonstration of species-specific and cross-reactive components of Taenia solium metacestode antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

Taenia solium: the complex interactions, of biological, social, geographical and commercial factors, involved in the transmission dynamics of pig cysticercosis in highly endemic areas

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

Genetic vaccination against murine cysticercosis by using a plasmid vector carrying Taenia solium paramyosin.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

Characterization and protective potential of the immune response to Taenia solium paramyosin in a murine model of cysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

Taenia crassiceps cysticercosis: protective effect and immune response elicited by DNA immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

Intrahepatic DNA vaccination: unexpected increased resistance against murine cysticercosis induced by non-specific enhanced immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

Immunodominant synthetic peptides of Taenia crassiceps in murine and human cysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

Effective protection against experimental Taenia solium tapeworm infection in hamsters by primo-infection and by vaccination with recombinant or synthetic heterologous antigens.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

Population genetic structure of Taenia solium from Madagascar and Mexico: implications for clinical profile diversity and immunological technology

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

Detection of genetic variation in Taenia solium.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

Therapeutic capacity of the synthetic peptide-based vaccine against Taenia solium cysticercosis in pigs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

The antipoverty vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

High order quaternary arrangement confers increased structural stability to Brucella sp. lumazine synthase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

Brucella lumazine synthase elicits a mixed Th1-Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulation used

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

Engineering of a polymeric bacterial protein as a scaffold for the multiple display of peptides.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

Brucella spp. lumazine synthase: a novel antigen delivery system.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

Brucella spp. lumazine synthase: a novel adjuvant and antigen delivery system to effectively induce oral immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

A novel synthetic adjuvant effectively enhances the immunogenicity of the influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

Characterization of excretory/secretory endopeptidase and metallo-aminopeptidases from Taenia crassiceps metacestodes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

Experimental Taenia solium cysticercosis in pigs: characteristics of the infection and antibody response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

The histopathology of porcine cysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

Where are the tapeworms?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

Prevalence and comparison of serologic assays, necropsy, and tongue examination for the diagnosis of porcine cysticercosis in Peru

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased resistance to Taenia crassiceps murine cysticercosis in Qa-2 transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

based on heuristic

inferred from DOI database lookup

Studies on immune responses to larval cestodes in mice. Increased susceptibility of certain mouse strains and hypothymic mice to Taenia taeniaeformis and analysis of passive transfer of resistance with serum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.018

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2006.10.018

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36692376&oldid=2183651102"